Loading...
Market
Will Patanjali Ayurved's market share in the Indian FMCG sector increase by 5% or more by December 31, 2024?
3
Supreme Court of India•Swami Ramdev•Patanjali Ayurved•Acharya Balakrishna•Patanjali•Ramdev•Balakrishna•Patanjali Ayurved Ltd
Resolution / Starting Odds
Yes • 50%
No • 50%
Market research reports and industry analysis
Story
Supreme Court Closes Contempt Case Against Ramdev and Acharya Balakrishna
Aug 13, 2024, 05:52 AM
The Supreme Court of India has closed the contempt case against yoga guru Swami Ramdev and Patanjali Ayurved's Managing Director, Acharya Balakrishna. The case involved allegations of misleading advertisements related to Patanjali products. The court accepted the undertakings from Ramdev and Balakrishna that they will cease issuing such misleading advertisements. This decision brings significant relief to Ramdev and Balakrishna, as well as their company, Patanjali Ayurved Ltd, which they co-founded.
View original story
Similar markets
Improved • 25%
Unchanged • 25%
Slightly worsened • 25%
Significantly worsened • 25%
Significant decline in market share • 25%
Moderate decline in market share • 25%
No significant change • 25%
Increase in market share • 25%
Fully compliant • 25%
Minor violations • 25%
Multiple violations • 25%
Major violations • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Mankind Pharma becomes the largest drug maker • 25%
Mankind Pharma becomes the second largest drug maker • 25%
Mankind Pharma remains the fourth largest drug maker • 25%
Mankind Pharma's ranking declines • 25%
